| 000 | 03194 a2200841 4500 | ||
|---|---|---|---|
| 005 | 20250514061730.0 | ||
| 264 | 0 | _c20030602 | |
| 008 | 200306s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/s0014-2999(03)01375-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYuan, Zhenfang | |
| 245 | 0 | 0 |
_aEffect of SNI-2011 on amylase secretion from parotid tissue in rats and in neuronal nitric oxide synthase knockout mice. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cMar 2003 |
||
| 300 |
_a197-206 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlkaloids _xpharmacology |
| 650 | 0 | 4 |
_aAmylases _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAzepines _xpharmacology |
| 650 | 0 | 4 |
_aBenzoates _xpharmacology |
| 650 | 0 | 4 |
_aBenzylamines _xpharmacology |
| 650 | 0 | 4 |
_aCalcium _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
| 650 | 0 | 4 | _aCalcium-Calmodulin-Dependent Protein Kinase Type 2 |
| 650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aCarbachol _xpharmacology |
| 650 | 0 | 4 | _aCarbazoles |
| 650 | 0 | 4 |
_aChelating Agents _xpharmacology |
| 650 | 0 | 4 |
_aCyclic GMP-Dependent Protein Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEgtazic Acid _xanalogs & derivatives |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aEstrenes _xpharmacology |
| 650 | 0 | 4 |
_aGallic Acid _xanalogs & derivatives |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aGuanylate Cyclase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIndoles _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aMolsidomine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aMuscarinic Agonists _xpharmacology |
| 650 | 0 | 4 |
_aMyosin-Light-Chain Kinase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide Donors _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type I |
| 650 | 0 | 4 |
_aOxadiazoles _xpharmacology |
| 650 | 0 | 4 |
_aParotid Gland _xdrug effects |
| 650 | 0 | 4 |
_aPenicillamine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPilocarpine _xpharmacology |
| 650 | 0 | 4 | _aProtein Kinase Inhibitors |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 650 | 0 | 4 |
_aPyrrolidinones _xpharmacology |
| 650 | 0 | 4 |
_aQuinoxalines _xpharmacology |
| 650 | 0 | 4 |
_aQuinuclidines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 | _aThiophenes |
| 650 | 0 | 4 |
_aType C Phospholipases _xantagonists & inhibitors |
| 700 | 1 | _aIida, Hirokazu | |
| 700 | 1 | _aInoue, Noriko | |
| 700 | 1 | _aIshikawa, Yasuko | |
| 700 | 1 | _aIshida, Hajime | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 464 _gno. 2-3 _gp. 197-206 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-2999(03)01375-x _zAvailable from publisher's website |
| 999 |
_c12416119 _d12416119 |
||